Nanox Secures $15 Million Registered Direct Offering
PETACH TIKVA, Israel – NANO-X IMAGING LTD (NASDAQ: NNOX), a pioneering medical imaging technology company, has announced its latest financial move—entering a securities purchase agreement with an institutional investor for 3,826,530 ordinary shares in a registered direct offering. This impressive transaction is set to bring in approximately $15 million in gross proceeds, paving the way for significant developments in the company’s operations.
Objective Behind the Funding
The net proceeds from this offering will primarily be channeled into working capital and various corporate purposes. Erez Meltzer, the Chief Executive Officer of Nanox, expressed his enthusiasm about this funding, stating that it will bolster the company’s balance sheet. He emphasized the need to accelerate growth initiatives which encompass enhancing their technology and expanding market presence.
Commitment to Health Care Accessibility
Meltzer further elaborated on how this capital raise is integral to advancing the company's mission of making high-quality medical imaging more accessible globally. This mission aligns with Nanox's commitment to leveraging innovative technologies to improve health outcomes and making preventive healthcare a reality.
The Role of Titan Partners Group
In facilitating this offering, Titan Partners Group, a part of American Capital Partners, has stepped in as the sole placement agent. Their involvement is expected to ensure that the offering processes align perfectly with regulatory expectations, ultimately benefiting Nanox and its stakeholders.
How the Proceeding Works
This registered direct offering is in compliance with the existing shelf registration that was recently filed with the U.S. Securities and Exchange Commission (SEC). Interested parties can access the official prospectus and related information through the SEC's website as well as Titan Partners Group once finalized. This transparent approach assures investors that they are engaging in a well-regulated environment.
About Nano-X Imaging Ltd.
Nanox (NASDAQ: NNOX) is not just another tech firm; it’s at the forefront of a historical shift towards preventative health care. By pioneering affordable medical imaging solutions that utilize advanced AI and a revolutionary digital X-ray source, Nanox is transforming the landscape of medical diagnostics.
Innovative Solutions in Medical Imaging
The vision at Nanox expands robustly. They aim to deliver comprehensive solutions that streamline the path from diagnosis to treatment. Central to this vision is the Nanox.ARC, a state-of-the-art digital tomosynthesis system that promises affordability without compromising on user experience.
Enhancing Diagnostic Processes
In addition to the hardware, Nanox is cultivating an AI-rich suite of algorithms through its subsidiary, Nanox.AI LTD. These algorithms assist in enhancing the interpretation of routine CT scans, specifically in identifying early signs linked with chronic diseases. This integration of AI is not merely an upgrade; it’s a game changer in how healthcare providers can diagnose and monitor patient health.
Comprehensive Data Management with Nanox.CLOUD
Another pillar of the Nanox ecosystem is Nanox.CLOUD—a comprehensive cloud platform designed to handle extensive data management. This system allows healthcare professionals to not only store but also analyze imaging data effectively, further optimizing the processes of diagnosis and reporting.
Market Opportunities and Future Prospects
As the healthcare industry continues evolving towards remote consultations and diagnostic evaluations, the Nanox.MARKETPLACE provides an innovative solution. This decentralized marketplace enhances access to radiology and cardiology experts, empowering healthcare systems to utilize their services efficiently while maintaining high standards.
Strengthening Partnerships for Better Health
Partnering with leaders in health tech, Nanox is working tirelessly to establish a network of collaborations that foster growth and innovation. By focusing on building sustainable relationships with key players, Nanox is in a strong position to navigate the complexities of the healthcare ecosystem.
Contact Information for Investors and Media
For further inquiries regarding this latest offering and other company-related questions, interested parties are encouraged to reach out to:
Investor Contact:
Mike Cavanaugh
ICR Healthcare
mike.cavanaugh@icrhealthcare.com
Media Contact:
Ben Shannon
ICR Healthcare
NanoxPR@icrinc.com
Frequently Asked Questions
What is Nanox's core business focus?
Nanox specializes in advanced medical imaging technologies aimed at making high-quality diagnostics accessible and affordable.
How much capital has Nanox raised in its latest offering?
Nanox has raised approximately $15 million in the recent registered direct offering.
Who is facilitating Nanox's current offering?
Titan Partners Group is acting as the sole placement agent for this offering.
What technologies does Nanox utilize?
Nanox employs cutting-edge AI algorithms alongside its unique digital X-ray source technology to enhance imaging solutions.
How can investors get in touch with Nanox?
Investors can contact Mike Cavanaugh through the provided email for inquiries regarding the company.
